Products
-
EU Clinical Trial Regulation (EU-CTR) Requirements -
EU Clinical Trial Regulation (EU-CTR) Requirements -
EU Guideline on Computerised Systems and Electronic Data in Clinical Trials -
Expediting Drug & Biologics Development: A Strategic Approach 2021 -
FDA Drug Approval Process -
FDA Medical Device Approval Process -
FDA Requirements for Electronic Source Data in Clinical Investigations -
FDA's Draft Guidance on Ethical Considerations for Clinical Investigations of Medical Products Involving Children -
FDA's February 2025 Guidance Update: Key Changes for IRBs and Clinical Investigators -
FDA's February 2025 Guidance Update: Key Changes for IRBs and Clinical Investigators -
FDA's Updated Informed Consent Guidance: WhatEEs New? -
FDAEEs Bioresearch Monitoring (BIMO) Program: Inspection of Sponsors, CROs, and Monitors -
FDAEEs Draft Guidance on Integrating Randomized Controlled Trials for Drug and Biological Products into Routine Clinical Practice -
FDAEEs Draft Guidance on Integrating Randomized Controlled Trials for Drug and Biological Products into Routine Clinical Practice -
Fundamentals of Good Clinical Practice (ICH E6 R2) -
GCP Renovation (ICH E8(R1) and ICH E6(R3)) -
GCP Renovation (ICH E8(R1) and ICH E6(R3)) -
Good Clinical Practice (GCP) for Medical Devices: ICH GCP E6 and ISO 14155 -
Good Clinical Practice for Investigators -
Good Clinical Practice for Sponsors & CROs (ICH E6 R2) -
Good Clinical Practice for Study Coordinators -
Good Clinical Practice: A Question & Answer Reference Guide 2020/2021 -
Good Clinical Practice: A Question & Answer Reference Guide 2020/2021 (Electronic) -
Good Clinical Practice: A Question & Answer Reference Guide 2024/2025